ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,157.06
0.57%
Dow Jones
38,776.74
0.26%
US Dollar vs MXN
16.90635
-0.46%
Brent Oil
83.33
0.25%
Bitcoin
63,159.46
-1.31%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. N4 Pharma Plc (N4P)

  7. N4 Pharma Plc (N4P) Noticias

N4P

N4 Pharma (N4P)

N4 Pharma Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:N4P
FechaHoraFuenteTítuloSímboloCompañía
29/04/202404:59RNS Regulatory NewsN4 Pharma PLC Posting of Annual Report & Notice of AGMLSE:N4PN4 Pharma Plc
26/04/202401:00RNS Non-RegulatoryN4 Pharma PLC N4 Pharma Webinar on SRI CollaborationLSE:N4PN4 Pharma Plc
25/04/202405:56Alliance NewsAlliance NewsN4 Pharma strikes partnership deal for intracellular deliveryLSE:N4PN4 Pharma Plc
25/04/202401:38RNS Regulatory NewsN4 Pharma PLC Collaboration Agreement with SRI International IncLSE:N4PN4 Pharma Plc
23/04/202407:32Alliance NewsAlliance NewsIN BRIEF: N4 Pharma loss widens but "great optimism" remainsLSE:N4PN4 Pharma Plc
23/04/202401:00RNS Regulatory NewsN4 Pharma PLC Final ResultsLSE:N4PN4 Pharma Plc
18/04/202406:14Alliance NewsAlliance NewsN4 Pharma sees potential in Nuvec delivery method for cancer treatmentLSE:N4PN4 Pharma Plc
18/04/202401:00RNS Regulatory NewsN4 Pharma PLC Oral Delivery UpdateLSE:N4PN4 Pharma Plc
04/03/202409:13RNS Regulatory NewsN4 Pharma PLC Holding(s) in CompanyLSE:N4PN4 Pharma Plc
15/02/202406:06Alliance NewsAlliance NewsIN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec researchLSE:N4PN4 Pharma Plc
15/02/202401:00RNS Regulatory NewsN4 Pharma PLC in-vitro siRNA updateLSE:N4PN4 Pharma Plc
19/01/202403:26Alliance NewsAlliance NewsIN BRIEF: N4 Pharma gets India patent for medical delivery systemLSE:N4PN4 Pharma Plc
19/01/202401:00UK RegulatoryN4 Pharma PLC Patent GrantLSE:N4PN4 Pharma Plc
16/01/202407:26Alliance NewsAlliance NewsIN BRIEF: N4 Pharma touts contract to test glaucoma treatment, ECP105LSE:N4PN4 Pharma Plc
16/01/202401:00UK RegulatoryN4 Pharma PLC Nanogenics UpdateLSE:N4PN4 Pharma Plc
08/01/202403:11Alliance NewsAlliance NewsN4 Pharma hails increased efficacy of Nuvec when complexed with AAV8LSE:N4PN4 Pharma Plc
08/01/202401:00UK RegulatoryN4 Pharma PLC AAV Viral Vector UpdateLSE:N4PN4 Pharma Plc
18/12/202306:43Alliance NewsAlliance NewsN4 Pharma rises on successful results from Nuvec administrationLSE:N4PN4 Pharma Plc
07/12/202312:28Alliance NewsAlliance NewsTRADING UPDATES: N4 Pharma hails "encouraging" siRNA researchLSE:N4PN4 Pharma Plc
07/12/202301:00UK RegulatoryN4 Pharma PLC Nuvec(R) R&D and Strategy UpdateLSE:N4PN4 Pharma Plc
01/12/202308:29Alliance NewsAlliance NewsTRADING UPDATES: N4 launches investor hub; Capricorn production fallsLSE:N4PN4 Pharma Plc
30/11/202303:00RNS Non-RegulatoryN4 Pharma PLC N4 Pharma Launches New Interactive Investor HubLSE:N4PN4 Pharma Plc
31/10/202302:00UK RegulatoryN4 Pharma PLC Total Voting RightsLSE:N4PN4 Pharma Plc
09/10/202301:00RNS Non-RegulatoryN4 Pharma PLC Investor Presentation via Investor Meet CompanyLSE:N4PN4 Pharma Plc
02/10/202301:00RNS Non-RegulatoryN4 Pharma PLC Investor PresentationLSE:N4PN4 Pharma Plc
28/09/202304:20Alliance NewsAlliance NewsN4 Pharma shares fall as places shares to fund Nanogenics stake buyLSE:N4PN4 Pharma Plc
28/09/202301:00UK RegulatoryN4 Pharma PLC Acquisition of Controlling Interest in NanogenicsLSE:N4PN4 Pharma Plc
12/09/202307:43Alliance NewsAlliance NewsN4 Pharma interim loss narrows slightly as business outreach ongoingLSE:N4PN4 Pharma Plc
12/09/202301:00UK RegulatoryN4 Pharma PLC Interim ResultsLSE:N4PN4 Pharma Plc
25/07/202304:12Alliance NewsAlliance NewsN4 Pharma shares soar on further patent grant for Nuvec in USLSE:N4PN4 Pharma Plc
 Showing the most relevant articles for your search:LSE:N4P

Su Consulta Reciente

NASDAQ
MSFT
Microsoft
COIN
SOLUSD
Solana
CCOM
SILVER
SILVER
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AMZN
Amazon.com
USOTC
DTEGY
Deutsche Telekom (QX)
USI
USTECH100
US Tech 100
NYSE
BAC
Bank of America
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
AMEX
SPY
SPDR S&P 500
COIN
ETHUSD
Ethereum
FX
EURMXN
Euro vs MXN
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados